Key result
A clinical and cardiopulmonary exercise nomogram predicts atrial fibrillation risk in HCM with ~0.87 AUC.
Why the study?
To investigate the relationship between cardiopulmonary exercise test parameters and the occurrence of atrial fibrillation in patients with hypertrophic cardiomyopathy.
Do cardiopulmonary exercise test parameters predict the occurrence of atrial fibrillation in patients with hypertrophic cardiomyopathy?
Observational (n=160)
No
Do cardiopulmonary exercise test parameters predict the occurrence of atrial fibrillation in patients with hypertrophic cardiomyopathy?
Effect estimate: OR 0.907 (95% CI 0.831-0.990)
p-value: p=0.030
Objective: To investigate the relationship between cardiopulmonary exercise test (CPET) parameters and the occurrence of atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM).Methods: A retrospective study was conducted on 160 HCM patients hospitalized at Quanzhou First Hospital Affiliated to Fujian Medical University from June 2020 to December 2023.Patients were divided into AF (n=62) and non-AF (n=98) groups.Univariate analysis and logistic regression were used to compare demographic and CPET parameters between groups.A nomogram model was developed to predict AF risk.Results: AF prevalence was 38.75%.Peak Oxygen Uptake per kilogram (Peak VO 2 /kg), Metabolic Equivalent of Task (METs), and Oxygen Uptake at Anaerobic threshold per kilogram (VO 2 /kg AT) were lower in the AF group compared to the non-AF group, while Ventilation to Carbon Dioxide Production Slope (VE/VCO 2 slope) was higher (all P<0.05).Pearson correlation analysis showed a significant negative correlation between Peak VO 2 /kg and New York Heart Association (NYHA) classification (r=-0.231,P=0.003).Logistic regression identified NYHA classification, smoking history, and VE/VCO 2 slope as risk factors for AF, while Peak VO 2 /kg, METs, and VO 2 /kg AT were protective factors (P<0.05).The nomogram model had an area under curve (AUC) of 0.867 (0.808-0.925), demonstrating good calibration and clinical utility.Conclusion: CPET parameters, combined with clinical indicators, can effectively predict AF risk in HCM patients.The nomogram model provides a valuable tool for clinical risk assessment.
No takes yet. Share an insight, caveat, or question.
Ling Wang (2025) conducted an observational in Hypertrophic cardiomyopathy (HCM) (n=160). Cardiopulmonary exercise test (CPET) parameters was evaluated on Atrial fibrillation occurrence (association with Peak VO2/kg) (OR 0.907, 95% CI 0.831-0.990, p=0.030). Cardiopulmonary exercise test parameters, including Peak VO2/kg (OR 0.907), combined with clinical indicators in a nomogram model, effectively predicted atrial fibrillation risk in hypertrophic cardiomyopathy patients with an AUC of 0.867.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: